Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Positron-Emission Tomography | 109 | 2023 | 6259 | 6.400 |
Why?
|
Carbon Radioisotopes | 37 | 2020 | 592 | 4.870 |
Why?
|
Histone Deacetylases | 18 | 2022 | 729 | 3.970 |
Why?
|
Radiopharmaceuticals | 36 | 2020 | 2658 | 3.410 |
Why?
|
Brain | 76 | 2023 | 26343 | 2.550 |
Why?
|
Adamantane | 8 | 2022 | 174 | 2.450 |
Why?
|
Hydroxamic Acids | 12 | 2022 | 495 | 2.220 |
Why?
|
Neurosciences | 5 | 2023 | 347 | 2.000 |
Why?
|
Histone Deacetylase Inhibitors | 14 | 2022 | 789 | 1.940 |
Why?
|
Fluorine Radioisotopes | 19 | 2020 | 448 | 1.670 |
Why?
|
Receptors, GABA | 15 | 2022 | 288 | 1.580 |
Why?
|
Papio | 19 | 2017 | 656 | 1.560 |
Why?
|
Diterpenes, Clerodane | 4 | 2015 | 43 | 1.520 |
Why?
|
Receptors, Opioid, kappa | 3 | 2018 | 144 | 1.370 |
Why?
|
Azepines | 4 | 2016 | 336 | 1.290 |
Why?
|
Palladium | 4 | 2017 | 65 | 1.220 |
Why?
|
Hallucinogens | 3 | 2023 | 180 | 1.130 |
Why?
|
Autistic Disorder | 4 | 2023 | 1174 | 1.110 |
Why?
|
Dopamine | 10 | 2023 | 1589 | 1.000 |
Why?
|
Pyrrolidines | 3 | 2018 | 342 | 0.990 |
Why?
|
Rats, Sprague-Dawley | 18 | 2022 | 8300 | 0.940 |
Why?
|
Isotope Labeling | 5 | 2017 | 414 | 0.920 |
Why?
|
Levivirus | 6 | 2008 | 13 | 0.870 |
Why?
|
Neuroglia | 7 | 2019 | 925 | 0.870 |
Why?
|
Capsid | 7 | 2011 | 436 | 0.840 |
Why?
|
Epigenomics | 5 | 2022 | 902 | 0.830 |
Why?
|
Radioactive Tracers | 5 | 2017 | 73 | 0.820 |
Why?
|
Benzamides | 8 | 2018 | 1378 | 0.820 |
Why?
|
Acetamides | 7 | 2021 | 249 | 0.770 |
Why?
|
Rats | 26 | 2022 | 24265 | 0.740 |
Why?
|
Epigenesis, Genetic | 9 | 2022 | 3639 | 0.740 |
Why?
|
Neurochemistry | 2 | 2019 | 29 | 0.720 |
Why?
|
Organometallic Compounds | 6 | 2015 | 665 | 0.710 |
Why?
|
Autoradiography | 4 | 2018 | 749 | 0.710 |
Why?
|
Amyotrophic Lateral Sclerosis | 9 | 2021 | 1421 | 0.710 |
Why?
|
Neurofibrillary Tangles | 1 | 2020 | 437 | 0.630 |
Why?
|
N-Methylaspartate | 1 | 2018 | 231 | 0.630 |
Why?
|
Tissue Distribution | 15 | 2021 | 2335 | 0.620 |
Why?
|
Macrocyclic Compounds | 1 | 2018 | 72 | 0.620 |
Why?
|
Olfactory Nerve | 1 | 2017 | 22 | 0.600 |
Why?
|
Histone Deacetylase 1 | 6 | 2022 | 137 | 0.590 |
Why?
|
Cyanides | 1 | 2017 | 83 | 0.590 |
Why?
|
Rodentia | 1 | 2018 | 262 | 0.580 |
Why?
|
Papio anubis | 8 | 2018 | 25 | 0.580 |
Why?
|
Animals | 77 | 2022 | 168561 | 0.570 |
Why?
|
Receptors, Dopamine D1 | 2 | 2016 | 291 | 0.550 |
Why?
|
Neuralgia | 1 | 2022 | 568 | 0.550 |
Why?
|
Phenylenediamines | 2 | 2013 | 90 | 0.550 |
Why?
|
Magnetic Resonance Imaging | 38 | 2023 | 35342 | 0.550 |
Why?
|
Olfactory Pathways | 1 | 2017 | 121 | 0.540 |
Why?
|
Prefrontal Cortex | 4 | 2020 | 2146 | 0.540 |
Why?
|
Molecular Structure | 12 | 2019 | 1907 | 0.540 |
Why?
|
Monoacylglycerol Lipases | 1 | 2016 | 48 | 0.530 |
Why?
|
Carbamates | 3 | 2016 | 195 | 0.530 |
Why?
|
Phosphines | 1 | 2015 | 18 | 0.520 |
Why?
|
Serotonin 5-HT2 Receptor Antagonists | 1 | 2014 | 21 | 0.500 |
Why?
|
Mental Disorders | 4 | 2023 | 6587 | 0.490 |
Why?
|
Psychomotor Disorders | 1 | 2015 | 152 | 0.480 |
Why?
|
Olfaction Disorders | 1 | 2017 | 222 | 0.480 |
Why?
|
Indoles | 3 | 2015 | 1834 | 0.480 |
Why?
|
Alzheimer Disease | 7 | 2022 | 7988 | 0.470 |
Why?
|
Serotonin 5-HT2 Receptor Agonists | 2 | 2013 | 38 | 0.470 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2018 | 1213 | 0.470 |
Why?
|
Raclopride | 9 | 2023 | 97 | 0.460 |
Why?
|
Receptors, Dopamine D2 | 7 | 2021 | 475 | 0.460 |
Why?
|
Tauopathies | 1 | 2017 | 307 | 0.450 |
Why?
|
Aldehydes | 1 | 2014 | 167 | 0.450 |
Why?
|
Serotonin Receptor Agonists | 1 | 2014 | 154 | 0.440 |
Why?
|
Receptor, Serotonin, 5-HT2C | 1 | 2012 | 44 | 0.440 |
Why?
|
Tritium | 1 | 2013 | 746 | 0.440 |
Why?
|
Capsid Proteins | 2 | 2008 | 479 | 0.440 |
Why?
|
Protein Isoforms | 2 | 2016 | 1727 | 0.420 |
Why?
|
Fluorobenzenes | 1 | 2014 | 184 | 0.420 |
Why?
|
Platinum Compounds | 1 | 2012 | 96 | 0.420 |
Why?
|
Fingers | 1 | 2015 | 514 | 0.410 |
Why?
|
Halogenation | 7 | 2022 | 42 | 0.410 |
Why?
|
Binding, Competitive | 4 | 2018 | 1159 | 0.400 |
Why?
|
Amides | 1 | 2014 | 458 | 0.390 |
Why?
|
Neurodegenerative Diseases | 1 | 2020 | 1060 | 0.390 |
Why?
|
Biological Assay | 1 | 2014 | 652 | 0.380 |
Why?
|
Metergoline | 1 | 2010 | 5 | 0.380 |
Why?
|
Dacarbazine | 2 | 2016 | 567 | 0.380 |
Why?
|
Analgesics, Opioid | 2 | 2018 | 3667 | 0.380 |
Why?
|
Central Nervous System | 2 | 2016 | 1354 | 0.370 |
Why?
|
Histone Deacetylase 2 | 4 | 2019 | 74 | 0.370 |
Why?
|
Fluorides | 4 | 2015 | 126 | 0.370 |
Why?
|
Pyridines | 8 | 2021 | 2818 | 0.370 |
Why?
|
Antibodies | 2 | 2018 | 2459 | 0.360 |
Why?
|
Nitriles | 1 | 2015 | 952 | 0.350 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2015 | 1107 | 0.350 |
Why?
|
Radiochemistry | 5 | 2020 | 56 | 0.350 |
Why?
|
Drug Delivery Systems | 4 | 2009 | 2217 | 0.350 |
Why?
|
Blast Injuries | 2 | 2023 | 302 | 0.340 |
Why?
|
Aminopyridines | 1 | 2013 | 541 | 0.340 |
Why?
|
Amyloid beta-Peptides | 2 | 2022 | 3574 | 0.340 |
Why?
|
Receptors, Dopamine D3 | 5 | 2022 | 110 | 0.340 |
Why?
|
Receptors, Serotonin | 1 | 2010 | 210 | 0.340 |
Why?
|
Central Nervous System Agents | 1 | 2009 | 72 | 0.330 |
Why?
|
Temperature | 2 | 2015 | 2207 | 0.330 |
Why?
|
Sex Characteristics | 1 | 2019 | 2585 | 0.330 |
Why?
|
Primates | 6 | 2021 | 543 | 0.330 |
Why?
|
Neurotransmitter Agents | 3 | 2019 | 647 | 0.330 |
Why?
|
Kinetics | 7 | 2021 | 6474 | 0.330 |
Why?
|
Carbon Dioxide | 2 | 2013 | 1141 | 0.330 |
Why?
|
Low Back Pain | 3 | 2022 | 955 | 0.330 |
Why?
|
Humans | 98 | 2023 | 742088 | 0.330 |
Why?
|
Diterpenes | 1 | 2009 | 173 | 0.330 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2012 | 627 | 0.320 |
Why?
|
Inflammation | 8 | 2020 | 10578 | 0.320 |
Why?
|
Male | 62 | 2022 | 349538 | 0.320 |
Why?
|
Pyrimidines | 6 | 2020 | 2933 | 0.300 |
Why?
|
Fluorine | 3 | 2022 | 83 | 0.300 |
Why?
|
Anti-Anxiety Agents | 1 | 2010 | 390 | 0.300 |
Why?
|
Molecular Imaging | 2 | 2019 | 831 | 0.300 |
Why?
|
Migraine with Aura | 2 | 2020 | 203 | 0.300 |
Why?
|
Sulfonamides | 2 | 2016 | 1932 | 0.300 |
Why?
|
Piperidines | 2 | 2017 | 1602 | 0.290 |
Why?
|
Peptides | 2 | 2017 | 4392 | 0.290 |
Why?
|
Arrhythmias, Cardiac | 1 | 2017 | 2267 | 0.290 |
Why?
|
Aniline Compounds | 2 | 2011 | 983 | 0.280 |
Why?
|
Formaldehyde | 1 | 2008 | 353 | 0.280 |
Why?
|
Models, Neurological | 5 | 2019 | 1771 | 0.270 |
Why?
|
Sensory Receptor Cells | 2 | 2022 | 487 | 0.260 |
Why?
|
Visual Perception | 1 | 2014 | 1417 | 0.260 |
Why?
|
Tomography Scanners, X-Ray Computed | 2 | 2016 | 168 | 0.260 |
Why?
|
Blood-Brain Barrier | 5 | 2014 | 1015 | 0.260 |
Why?
|
Editorial Policies | 2 | 2021 | 451 | 0.260 |
Why?
|
Heart | 2 | 2017 | 4462 | 0.240 |
Why?
|
Dose-Response Relationship, Drug | 8 | 2018 | 10943 | 0.240 |
Why?
|
Military Personnel | 2 | 2023 | 1132 | 0.240 |
Why?
|
Histone Demethylases | 2 | 2016 | 320 | 0.230 |
Why?
|
Carbon Isotopes | 5 | 2017 | 468 | 0.230 |
Why?
|
Bipolar Disorder | 2 | 2020 | 5024 | 0.230 |
Why?
|
Methylation | 3 | 2017 | 1107 | 0.230 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 3 | 2011 | 422 | 0.230 |
Why?
|
Schizophrenia | 3 | 2018 | 6874 | 0.230 |
Why?
|
Capillary Permeability | 2 | 2019 | 798 | 0.230 |
Why?
|
Glucose | 2 | 2023 | 4391 | 0.220 |
Why?
|
Zebrafish Proteins | 2 | 2019 | 1004 | 0.220 |
Why?
|
Spinal Nerves | 1 | 2022 | 86 | 0.220 |
Why?
|
Dopamine Antagonists | 5 | 2015 | 296 | 0.210 |
Why?
|
Macaca mulatta | 6 | 2020 | 2378 | 0.210 |
Why?
|
Gadolinium | 1 | 2007 | 951 | 0.210 |
Why?
|
Purinergic P1 Receptor Agonists | 1 | 2021 | 38 | 0.210 |
Why?
|
Drug Design | 5 | 2015 | 1078 | 0.200 |
Why?
|
Neuronal Plasticity | 2 | 2023 | 1418 | 0.200 |
Why?
|
Cerebrovascular Circulation | 4 | 2021 | 2732 | 0.200 |
Why?
|
Kidney | 2 | 2014 | 7167 | 0.200 |
Why?
|
Adult | 36 | 2022 | 213712 | 0.200 |
Why?
|
Radioligand Assay | 2 | 2014 | 379 | 0.200 |
Why?
|
Nuclear Proteins | 1 | 2016 | 5851 | 0.200 |
Why?
|
Cyclization | 2 | 2014 | 65 | 0.200 |
Why?
|
Female | 49 | 2022 | 379592 | 0.190 |
Why?
|
Protein Binding | 6 | 2019 | 9387 | 0.190 |
Why?
|
Brain Diseases | 2 | 2021 | 1554 | 0.190 |
Why?
|
Enzyme Inhibitors | 4 | 2016 | 3800 | 0.190 |
Why?
|
Brain Mapping | 7 | 2018 | 6669 | 0.190 |
Why?
|
Zebrafish | 3 | 2022 | 2990 | 0.190 |
Why?
|
Image Processing, Computer-Assisted | 8 | 2020 | 8925 | 0.190 |
Why?
|
Fluorodeoxyglucose F18 | 4 | 2014 | 2013 | 0.190 |
Why?
|
Corpus Striatum | 4 | 2021 | 1220 | 0.190 |
Why?
|
Motor Cortex | 2 | 2019 | 984 | 0.180 |
Why?
|
Receptors, Serotonin, 5-HT2 | 1 | 2020 | 8 | 0.180 |
Why?
|
Spinal Cord | 2 | 2019 | 1807 | 0.180 |
Why?
|
Ganglia, Spinal | 1 | 2022 | 517 | 0.180 |
Why?
|
Proteins | 3 | 2016 | 6096 | 0.180 |
Why?
|
Blood Glucose | 1 | 2014 | 6249 | 0.180 |
Why?
|
Glycolysis | 1 | 2023 | 825 | 0.170 |
Why?
|
Aging | 3 | 2017 | 8626 | 0.170 |
Why?
|
Sulfhydryl Compounds | 2 | 2017 | 296 | 0.170 |
Why?
|
Triazoles | 3 | 2016 | 907 | 0.170 |
Why?
|
Young Adult | 15 | 2022 | 56350 | 0.170 |
Why?
|
Chromosome Disorders | 1 | 2021 | 515 | 0.170 |
Why?
|
Magnetic Resonance Spectroscopy | 6 | 2021 | 3760 | 0.160 |
Why?
|
Meninges | 1 | 2020 | 190 | 0.160 |
Why?
|
Clioquinol | 1 | 2018 | 23 | 0.160 |
Why?
|
Food | 1 | 2023 | 769 | 0.160 |
Why?
|
Thalamus | 2 | 2014 | 1023 | 0.160 |
Why?
|
Drug Discovery | 2 | 2016 | 1057 | 0.160 |
Why?
|
Serotonin 5-HT1 Receptor Antagonists | 1 | 2017 | 10 | 0.160 |
Why?
|
Myocytes, Cardiac | 2 | 2017 | 1636 | 0.160 |
Why?
|
Drug Partial Agonism | 1 | 2017 | 25 | 0.160 |
Why?
|
Spinal Nerve Roots | 1 | 2018 | 124 | 0.160 |
Why?
|
Encephalitis | 2 | 2019 | 423 | 0.150 |
Why?
|
Dihydrotestosterone | 1 | 2018 | 188 | 0.150 |
Why?
|
Biomedical Engineering | 1 | 2019 | 295 | 0.150 |
Why?
|
Serotonin 5-HT1 Receptor Agonists | 1 | 2017 | 46 | 0.150 |
Why?
|
Receptors, Islet Amyloid Polypeptide | 1 | 2017 | 2 | 0.150 |
Why?
|
Hypercapnia | 2 | 2021 | 260 | 0.150 |
Why?
|
Contrast Media | 2 | 2008 | 5295 | 0.150 |
Why?
|
Periodicals as Topic | 2 | 2019 | 1431 | 0.150 |
Why?
|
Motor Neuron Disease | 1 | 2017 | 106 | 0.150 |
Why?
|
Glucans | 1 | 2017 | 72 | 0.150 |
Why?
|
Adenosine Triphosphate | 1 | 2023 | 2024 | 0.150 |
Why?
|
Transcription Factors | 1 | 2016 | 12164 | 0.140 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2019 | 11472 | 0.140 |
Why?
|
Technology, Pharmaceutical | 1 | 2016 | 85 | 0.140 |
Why?
|
Case-Control Studies | 7 | 2021 | 21719 | 0.140 |
Why?
|
Synaptophysin | 1 | 2016 | 141 | 0.140 |
Why?
|
tau Proteins | 3 | 2022 | 1860 | 0.140 |
Why?
|
Administration, Intranasal | 1 | 2017 | 446 | 0.140 |
Why?
|
Disease Models, Animal | 7 | 2017 | 18006 | 0.140 |
Why?
|
Nucleus Accumbens | 2 | 2017 | 366 | 0.140 |
Why?
|
Tetrahydronaphthalenes | 1 | 2016 | 89 | 0.140 |
Why?
|
Brain Neoplasms | 2 | 2019 | 8829 | 0.140 |
Why?
|
Depressive Disorder, Major | 3 | 2023 | 4628 | 0.140 |
Why?
|
Inhibitory Concentration 50 | 2 | 2014 | 459 | 0.140 |
Why?
|
Quinpirole | 1 | 2015 | 32 | 0.140 |
Why?
|
Radiculopathy | 1 | 2018 | 194 | 0.130 |
Why?
|
Motor Neurons | 2 | 2021 | 851 | 0.130 |
Why?
|
Liver Cirrhosis | 2 | 2016 | 1864 | 0.130 |
Why?
|
Behavior, Animal | 3 | 2017 | 1882 | 0.130 |
Why?
|
alpha 1-Antitrypsin Deficiency | 1 | 2016 | 107 | 0.130 |
Why?
|
Dopamine Agonists | 2 | 2015 | 355 | 0.130 |
Why?
|
Phenyl Ethers | 1 | 2015 | 58 | 0.130 |
Why?
|
Sex Hormone-Binding Globulin | 1 | 2018 | 548 | 0.130 |
Why?
|
Middle Aged | 27 | 2022 | 213127 | 0.130 |
Why?
|
RNA, Viral | 1 | 2004 | 2899 | 0.130 |
Why?
|
Manganese | 2 | 2015 | 408 | 0.130 |
Why?
|
Cytoprotection | 1 | 2015 | 210 | 0.130 |
Why?
|
Enoyl-(Acyl-Carrier-Protein) Reductase (NADH) | 1 | 2014 | 6 | 0.130 |
Why?
|
Early Diagnosis | 1 | 2020 | 1184 | 0.130 |
Why?
|
Models, Chemical | 4 | 2014 | 626 | 0.130 |
Why?
|
Tropanes | 2 | 2011 | 51 | 0.130 |
Why?
|
Drug Approval | 1 | 2021 | 740 | 0.120 |
Why?
|
Whole Body Imaging | 1 | 2017 | 280 | 0.120 |
Why?
|
Motor Activity | 4 | 2014 | 2714 | 0.120 |
Why?
|
Databases, Bibliographic | 1 | 2015 | 128 | 0.120 |
Why?
|
Injections, Intravenous | 3 | 2017 | 1420 | 0.120 |
Why?
|
Cannabis | 1 | 2021 | 432 | 0.120 |
Why?
|
Organ Culture Techniques | 1 | 2017 | 808 | 0.120 |
Why?
|
Elasticity Imaging Techniques | 2 | 2016 | 388 | 0.120 |
Why?
|
Receptor, Serotonin, 5-HT2A | 1 | 2014 | 74 | 0.120 |
Why?
|
Zinc | 1 | 2018 | 683 | 0.120 |
Why?
|
Fibromyalgia | 1 | 2018 | 388 | 0.120 |
Why?
|
Multiple Sclerosis, Chronic Progressive | 1 | 2016 | 236 | 0.120 |
Why?
|
Object Attachment | 1 | 2017 | 313 | 0.120 |
Why?
|
Placebo Effect | 1 | 2017 | 502 | 0.120 |
Why?
|
Trimethylsilyl Compounds | 1 | 2013 | 8 | 0.120 |
Why?
|
Sodium Iodide | 1 | 2013 | 13 | 0.120 |
Why?
|
Carbonates | 1 | 2013 | 21 | 0.120 |
Why?
|
Publishing | 1 | 2021 | 833 | 0.120 |
Why?
|
Cesium | 1 | 2013 | 38 | 0.120 |
Why?
|
Benzofurans | 1 | 2014 | 140 | 0.110 |
Why?
|
Time | 1 | 2015 | 530 | 0.110 |
Why?
|
Amidohydrolases | 1 | 2014 | 169 | 0.110 |
Why?
|
Pilot Projects | 5 | 2022 | 8297 | 0.110 |
Why?
|
Affect | 2 | 2013 | 1473 | 0.110 |
Why?
|
United States Food and Drug Administration | 1 | 2021 | 1581 | 0.110 |
Why?
|
Nerve Net | 2 | 2016 | 2174 | 0.110 |
Why?
|
Mycobacterium tuberculosis | 2 | 2015 | 1825 | 0.110 |
Why?
|
Oxazoles | 1 | 2014 | 189 | 0.110 |
Why?
|
Chromatography, Liquid | 2 | 2014 | 977 | 0.110 |
Why?
|
Isonicotinic Acids | 1 | 2012 | 8 | 0.110 |
Why?
|
Pyrazoles | 2 | 2021 | 1970 | 0.110 |
Why?
|
Analgesia | 1 | 2017 | 459 | 0.110 |
Why?
|
Oxidoreductases | 1 | 2015 | 424 | 0.110 |
Why?
|
Mother-Child Relations | 1 | 2017 | 481 | 0.110 |
Why?
|
Heart Failure | 1 | 2017 | 10856 | 0.110 |
Why?
|
Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2013 | 113 | 0.110 |
Why?
|
Unconsciousness | 1 | 2014 | 262 | 0.110 |
Why?
|
Computers | 1 | 2015 | 611 | 0.110 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2016 | 604 | 0.110 |
Why?
|
Metals | 1 | 2017 | 717 | 0.110 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2017 | 895 | 0.100 |
Why?
|
Elementary Particles | 1 | 2012 | 55 | 0.100 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2016 | 670 | 0.100 |
Why?
|
Nickel | 1 | 2012 | 130 | 0.100 |
Why?
|
Half-Life | 1 | 2013 | 658 | 0.100 |
Why?
|
Locomotion | 2 | 2018 | 378 | 0.100 |
Why?
|
Benzazepines | 1 | 2014 | 326 | 0.100 |
Why?
|
Image Enhancement | 2 | 2017 | 2921 | 0.100 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2019 | 1221 | 0.100 |
Why?
|
Up-Regulation | 2 | 2021 | 4211 | 0.100 |
Why?
|
HeLa Cells | 2 | 2016 | 3127 | 0.100 |
Why?
|
Huntington Disease | 1 | 2018 | 1111 | 0.100 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 1 | 2016 | 520 | 0.100 |
Why?
|
Cerebral Cortex | 3 | 2019 | 5705 | 0.100 |
Why?
|
Aminophenols | 1 | 2011 | 78 | 0.100 |
Why?
|
Brain Concussion | 1 | 2022 | 1318 | 0.100 |
Why?
|
Platinum | 1 | 2012 | 232 | 0.100 |
Why?
|
Hydrazines | 1 | 2012 | 220 | 0.100 |
Why?
|
Diffusion Tensor Imaging | 2 | 2018 | 2304 | 0.100 |
Why?
|
Data Interpretation, Statistical | 2 | 2019 | 2714 | 0.090 |
Why?
|
Area Under Curve | 1 | 2015 | 1653 | 0.090 |
Why?
|
Alcoholism | 1 | 2021 | 1904 | 0.090 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2016 | 503 | 0.090 |
Why?
|
Aged | 17 | 2020 | 162944 | 0.090 |
Why?
|
Anilides | 2 | 2013 | 404 | 0.090 |
Why?
|
Brain Injuries | 1 | 2022 | 2024 | 0.090 |
Why?
|
Ligands | 2 | 2017 | 3293 | 0.090 |
Why?
|
Basal Ganglia | 1 | 2013 | 545 | 0.090 |
Why?
|
Tissue Donors | 1 | 2019 | 2205 | 0.090 |
Why?
|
Receptors, Vasopressin | 1 | 2010 | 112 | 0.090 |
Why?
|
Synapses | 1 | 2019 | 1724 | 0.090 |
Why?
|
Memory, Short-Term | 1 | 2016 | 972 | 0.090 |
Why?
|
Mass Spectrometry | 2 | 2014 | 2203 | 0.090 |
Why?
|
Structure-Activity Relationship | 3 | 2022 | 3133 | 0.090 |
Why?
|
Renin-Angiotensin System | 1 | 2014 | 759 | 0.090 |
Why?
|
Action Potentials | 1 | 2017 | 1814 | 0.090 |
Why?
|
Prostheses and Implants | 1 | 2017 | 1385 | 0.090 |
Why?
|
Azabicyclo Compounds | 1 | 2009 | 68 | 0.080 |
Why?
|
Reproducibility of Results | 5 | 2020 | 19862 | 0.080 |
Why?
|
Oxidation-Reduction | 3 | 2012 | 2187 | 0.080 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2016 | 1675 | 0.080 |
Why?
|
Neoplasm Proteins | 1 | 2021 | 3691 | 0.080 |
Why?
|
Mice, Inbred C57BL | 5 | 2018 | 21821 | 0.080 |
Why?
|
Injections, Intraperitoneal | 1 | 2009 | 424 | 0.080 |
Why?
|
Feasibility Studies | 2 | 2020 | 5062 | 0.080 |
Why?
|
Gene Expression Regulation | 3 | 2017 | 12071 | 0.080 |
Why?
|
Aromatase | 1 | 2009 | 146 | 0.080 |
Why?
|
Delirium | 1 | 2020 | 1608 | 0.080 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 2276 | 0.080 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2021 | 2407 | 0.080 |
Why?
|
Mice | 13 | 2021 | 81045 | 0.080 |
Why?
|
Benzaldehydes | 1 | 2008 | 58 | 0.080 |
Why?
|
Statistics as Topic | 1 | 2015 | 2372 | 0.080 |
Why?
|
Insulin-Secreting Cells | 1 | 2015 | 891 | 0.080 |
Why?
|
Microscopy, Confocal | 1 | 2014 | 1969 | 0.080 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2018 | 2940 | 0.080 |
Why?
|
Spin Labels | 2 | 2021 | 332 | 0.080 |
Why?
|
Coumarins | 1 | 2008 | 119 | 0.080 |
Why?
|
Nicotinic Agonists | 1 | 2010 | 271 | 0.080 |
Why?
|
Sleep | 1 | 2023 | 4604 | 0.080 |
Why?
|
Methods | 1 | 2008 | 1128 | 0.080 |
Why?
|
Metabolism | 1 | 2009 | 193 | 0.080 |
Why?
|
Emotions | 1 | 2019 | 2657 | 0.070 |
Why?
|
Tomography, X-Ray Computed | 4 | 2020 | 20086 | 0.070 |
Why?
|
ROC Curve | 1 | 2015 | 3528 | 0.070 |
Why?
|
Cocaine | 2 | 2009 | 1008 | 0.070 |
Why?
|
Receptors, Cell Surface | 1 | 2016 | 2867 | 0.070 |
Why?
|
Psychotic Disorders | 2 | 2018 | 3040 | 0.070 |
Why?
|
Anti-Bacterial Agents | 2 | 2015 | 7153 | 0.070 |
Why?
|
Oximes | 1 | 2008 | 309 | 0.070 |
Why?
|
Cisplatin | 1 | 2012 | 1637 | 0.070 |
Why?
|
Neurogenesis | 1 | 2013 | 829 | 0.070 |
Why?
|
Fibroblasts | 1 | 2017 | 4143 | 0.070 |
Why?
|
Staphylococcus aureus | 1 | 2014 | 1449 | 0.070 |
Why?
|
Nerve Tissue Proteins | 1 | 2019 | 4465 | 0.070 |
Why?
|
Aromatase Inhibitors | 1 | 2010 | 491 | 0.070 |
Why?
|
Myocardial Ischemia | 1 | 2017 | 2145 | 0.070 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2012 | 810 | 0.070 |
Why?
|
Nervous System Diseases | 1 | 2016 | 1617 | 0.070 |
Why?
|
Sodium Chloride | 2 | 2018 | 625 | 0.070 |
Why?
|
Receptors, Opioid | 2 | 2017 | 155 | 0.070 |
Why?
|
Molecular Weight | 1 | 2008 | 2255 | 0.070 |
Why?
|
Light | 1 | 2012 | 1374 | 0.070 |
Why?
|
Solvents | 2 | 2022 | 302 | 0.070 |
Why?
|
Cocaine-Related Disorders | 1 | 2009 | 460 | 0.070 |
Why?
|
Antirheumatic Agents | 1 | 2015 | 1335 | 0.070 |
Why?
|
Blotting, Western | 1 | 2013 | 5180 | 0.070 |
Why?
|
Migraine Disorders | 1 | 2017 | 1620 | 0.070 |
Why?
|
Staphylococcal Infections | 1 | 2014 | 1398 | 0.060 |
Why?
|
Antidepressive Agents | 2 | 2014 | 2838 | 0.060 |
Why?
|
Nanoparticles | 1 | 2017 | 1902 | 0.060 |
Why?
|
Cell Cycle Proteins | 1 | 2016 | 3444 | 0.060 |
Why?
|
Nicotine | 1 | 2010 | 677 | 0.060 |
Why?
|
Interleukin-6 | 1 | 2015 | 3199 | 0.060 |
Why?
|
Oxygen | 1 | 2016 | 4169 | 0.060 |
Why?
|
Piperazines | 1 | 2015 | 2488 | 0.060 |
Why?
|
Antipsychotic Agents | 1 | 2018 | 3058 | 0.060 |
Why?
|
Glioblastoma | 1 | 2019 | 3456 | 0.060 |
Why?
|
Cues | 1 | 2009 | 868 | 0.060 |
Why?
|
Neural Pathways | 1 | 2014 | 2971 | 0.060 |
Why?
|
Genotype | 2 | 2016 | 12946 | 0.060 |
Why?
|
Protein Conformation | 2 | 2018 | 4013 | 0.060 |
Why?
|
Pain | 2 | 2018 | 4961 | 0.060 |
Why?
|
Putamen | 2 | 2018 | 291 | 0.060 |
Why?
|
Explosions | 1 | 2023 | 109 | 0.060 |
Why?
|
Dogs | 1 | 2008 | 3910 | 0.060 |
Why?
|
Particle Size | 1 | 2007 | 1640 | 0.060 |
Why?
|
Bioreactors | 1 | 2004 | 236 | 0.050 |
Why?
|
Catalysis | 2 | 2015 | 760 | 0.050 |
Why?
|
Benzhydryl Compounds | 1 | 2009 | 840 | 0.050 |
Why?
|
Time Factors | 6 | 2015 | 40054 | 0.050 |
Why?
|
Nanostructures | 1 | 2008 | 550 | 0.050 |
Why?
|
Autoimmune Diseases | 1 | 2014 | 2130 | 0.050 |
Why?
|
Presenilin-1 | 2 | 2017 | 635 | 0.050 |
Why?
|
Age Factors | 1 | 2019 | 18355 | 0.050 |
Why?
|
Diagnostic Imaging | 2 | 2018 | 3507 | 0.050 |
Why?
|
Fluoroacetates | 2 | 2013 | 14 | 0.050 |
Why?
|
Hypertension | 1 | 2022 | 8455 | 0.050 |
Why?
|
Multiple Sclerosis | 1 | 2017 | 3076 | 0.050 |
Why?
|
Macrophages | 1 | 2017 | 5655 | 0.050 |
Why?
|
Adolescent | 6 | 2020 | 85649 | 0.050 |
Why?
|
Antitubercular Agents | 1 | 2010 | 1319 | 0.050 |
Why?
|
Bacterial Proteins | 1 | 2015 | 3843 | 0.050 |
Why?
|
Pandemics | 1 | 2022 | 8328 | 0.050 |
Why?
|
Chromatin | 1 | 2013 | 2917 | 0.050 |
Why?
|
Sensitivity and Specificity | 3 | 2017 | 14720 | 0.050 |
Why?
|
Depressive Disorder | 1 | 2014 | 3748 | 0.050 |
Why?
|
Myocardium | 1 | 2014 | 4775 | 0.050 |
Why?
|
Hot Temperature | 1 | 2007 | 1355 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2019 | 9185 | 0.050 |
Why?
|
Astrocytes | 2 | 2018 | 1266 | 0.050 |
Why?
|
Crystallography, X-Ray | 2 | 2018 | 2014 | 0.050 |
Why?
|
Nucleic Acid Conformation | 1 | 2004 | 914 | 0.050 |
Why?
|
Amyloid beta-Protein Precursor | 2 | 2017 | 1121 | 0.050 |
Why?
|
Hippocampus | 1 | 2013 | 3661 | 0.050 |
Why?
|
Central Nervous System Stimulants | 1 | 2009 | 1148 | 0.050 |
Why?
|
Phosphoric Diester Hydrolases | 1 | 2021 | 197 | 0.050 |
Why?
|
Microglia | 2 | 2018 | 1261 | 0.040 |
Why?
|
Swine | 2 | 2020 | 5934 | 0.040 |
Why?
|
United States | 3 | 2023 | 69693 | 0.040 |
Why?
|
Cross-Sectional Studies | 5 | 2019 | 24913 | 0.040 |
Why?
|
Viral Proteins | 1 | 2007 | 1899 | 0.040 |
Why?
|
Chemotherapy, Cancer, Regional Perfusion | 1 | 2019 | 83 | 0.040 |
Why?
|
Primary Health Care | 1 | 2015 | 4551 | 0.040 |
Why?
|
Cyclic GMP | 1 | 2020 | 408 | 0.040 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2019 | 407 | 0.040 |
Why?
|
DNA | 1 | 2012 | 7289 | 0.040 |
Why?
|
Occipital Lobe | 1 | 2020 | 380 | 0.040 |
Why?
|
Cell Proliferation | 1 | 2014 | 10472 | 0.040 |
Why?
|
Algorithms | 2 | 2017 | 13853 | 0.040 |
Why?
|
Authorship | 1 | 2021 | 271 | 0.040 |
Why?
|
Phencyclidine | 1 | 2017 | 61 | 0.040 |
Why?
|
Receptor, Serotonin, 5-HT1B | 1 | 2017 | 38 | 0.040 |
Why?
|
Thalamic Nuclei | 1 | 2018 | 114 | 0.040 |
Why?
|
Dizocilpine Maleate | 1 | 2017 | 176 | 0.040 |
Why?
|
Islet Amyloid Polypeptide | 1 | 2017 | 41 | 0.040 |
Why?
|
Catalytic Domain | 1 | 2019 | 699 | 0.040 |
Why?
|
Chromatography, High Pressure Liquid | 2 | 2012 | 1574 | 0.040 |
Why?
|
Globus Pallidus | 1 | 2018 | 253 | 0.040 |
Why?
|
Depression | 2 | 2022 | 7733 | 0.040 |
Why?
|
Models, Molecular | 3 | 2014 | 5454 | 0.040 |
Why?
|
Neuroimmunomodulation | 1 | 2018 | 152 | 0.040 |
Why?
|
Coordination Complexes | 1 | 2018 | 115 | 0.040 |
Why?
|
Retinoid X Receptors | 1 | 2016 | 93 | 0.040 |
Why?
|
Imidazolines | 1 | 2016 | 18 | 0.040 |
Why?
|
Perfusion | 1 | 2021 | 1359 | 0.040 |
Why?
|
Blood Proteins | 2 | 2013 | 1122 | 0.040 |
Why?
|
Cohort Studies | 4 | 2021 | 40450 | 0.040 |
Why?
|
Cross-Over Studies | 1 | 2022 | 2030 | 0.040 |
Why?
|
Signal Transduction | 2 | 2018 | 23387 | 0.040 |
Why?
|
Disulfiram | 1 | 2016 | 57 | 0.040 |
Why?
|
Gene Expression | 1 | 2009 | 7790 | 0.040 |
Why?
|
Cortical Spreading Depression | 1 | 2020 | 276 | 0.040 |
Why?
|
Adenosine | 1 | 2021 | 823 | 0.040 |
Why?
|
Mice, Inbred BALB C | 2 | 2018 | 6382 | 0.030 |
Why?
|
Histones | 2 | 2019 | 2597 | 0.030 |
Why?
|
Prochlorperazine | 1 | 2015 | 17 | 0.030 |
Why?
|
Methamphetamine | 1 | 2017 | 152 | 0.030 |
Why?
|
Diagnosis | 1 | 2016 | 154 | 0.030 |
Why?
|
Administration, Inhalation | 1 | 2018 | 1104 | 0.030 |
Why?
|
Decarboxylation | 1 | 2015 | 6 | 0.030 |
Why?
|
Escherichia coli | 2 | 2007 | 4214 | 0.030 |
Why?
|
Skull | 1 | 2020 | 810 | 0.030 |
Why?
|
Iodobenzenes | 1 | 2015 | 24 | 0.030 |
Why?
|
Anxiety | 1 | 2010 | 4279 | 0.030 |
Why?
|
Publications | 1 | 2018 | 195 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2015 | 15494 | 0.030 |
Why?
|
Prostatic Neoplasms | 1 | 2018 | 11039 | 0.030 |
Why?
|
Interferon Inducers | 1 | 2014 | 25 | 0.030 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 2017 | 449 | 0.030 |
Why?
|
Maze Learning | 1 | 2017 | 478 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2017 | 17400 | 0.030 |
Why?
|
Communicable Disease Control | 1 | 2022 | 854 | 0.030 |
Why?
|
Diprenorphine | 1 | 2014 | 13 | 0.030 |
Why?
|
Electrons | 1 | 2016 | 268 | 0.030 |
Why?
|
Muscle Strength | 1 | 2018 | 586 | 0.030 |
Why?
|
Disulfides | 1 | 2016 | 457 | 0.030 |
Why?
|
Ethylenediamines | 1 | 2014 | 48 | 0.030 |
Why?
|
Ions | 1 | 2015 | 264 | 0.030 |
Why?
|
Water | 2 | 2012 | 1388 | 0.030 |
Why?
|
Infusions, Intravenous | 1 | 2018 | 2271 | 0.030 |
Why?
|
Pain Threshold | 1 | 2017 | 585 | 0.030 |
Why?
|
Butyric Acid | 1 | 2013 | 55 | 0.030 |
Why?
|
Reference Standards | 1 | 2017 | 1020 | 0.030 |
Why?
|
GTP-Binding Proteins | 1 | 2018 | 970 | 0.030 |
Why?
|
Biological Transport | 1 | 2018 | 2119 | 0.030 |
Why?
|
Models, Animal | 1 | 2020 | 2170 | 0.030 |
Why?
|
Mice, Transgenic | 2 | 2017 | 9735 | 0.030 |
Why?
|
Endocannabinoids | 1 | 2014 | 116 | 0.030 |
Why?
|
Phenylbutyrates | 1 | 2013 | 69 | 0.030 |
Why?
|
Placebos | 1 | 2017 | 1677 | 0.030 |
Why?
|
Hydrogen Peroxide | 1 | 2016 | 730 | 0.030 |
Why?
|
Drug Interactions | 1 | 2017 | 1458 | 0.030 |
Why?
|
Cell Line, Tumor | 3 | 2018 | 16665 | 0.030 |
Why?
|
Chromatography, Thin Layer | 1 | 2012 | 223 | 0.030 |
Why?
|
Oxytocin | 1 | 2017 | 395 | 0.030 |
Why?
|
RNA, Messenger | 2 | 2019 | 13029 | 0.030 |
Why?
|
Drug Evaluation | 1 | 2014 | 637 | 0.030 |
Why?
|
Iodine | 1 | 2015 | 285 | 0.030 |
Why?
|
Spectrophotometry, Ultraviolet | 1 | 2012 | 220 | 0.030 |
Why?
|
Firefly Luciferin | 1 | 2012 | 10 | 0.030 |
Why?
|
Carbon | 1 | 2016 | 686 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2018 | 1372 | 0.030 |
Why?
|
Prevalence | 2 | 2022 | 15194 | 0.030 |
Why?
|
Paroxetine | 1 | 2013 | 182 | 0.030 |
Why?
|
Phenols | 1 | 2016 | 501 | 0.030 |
Why?
|
Calcium-Binding Proteins | 1 | 2017 | 1081 | 0.030 |
Why?
|
Cysteine | 1 | 2016 | 873 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2019 | 4751 | 0.030 |
Why?
|
Ketamine | 1 | 2017 | 499 | 0.030 |
Why?
|
Quality of Life | 2 | 2023 | 12730 | 0.030 |
Why?
|
Waist Circumference | 1 | 2015 | 917 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2015 | 11695 | 0.020 |
Why?
|
Permeability | 1 | 2013 | 738 | 0.020 |
Why?
|
Microfilament Proteins | 1 | 2017 | 1152 | 0.020 |
Why?
|
Solutions | 1 | 2012 | 426 | 0.020 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2014 | 365 | 0.020 |
Why?
|
Cognition | 1 | 2009 | 6722 | 0.020 |
Why?
|
Animals, Newborn | 1 | 2017 | 2723 | 0.020 |
Why?
|
History, 21st Century | 1 | 2017 | 1533 | 0.020 |
Why?
|
Overweight | 1 | 2022 | 2366 | 0.020 |
Why?
|
Indicators and Reagents | 1 | 2011 | 462 | 0.020 |
Why?
|
Valproic Acid | 1 | 2013 | 446 | 0.020 |
Why?
|
Acetylation | 1 | 2013 | 1085 | 0.020 |
Why?
|
Rabbits | 1 | 2017 | 4886 | 0.020 |
Why?
|
Dexmedetomidine | 1 | 2014 | 315 | 0.020 |
Why?
|
Lithium | 1 | 2013 | 601 | 0.020 |
Why?
|
Reward | 1 | 2017 | 940 | 0.020 |
Why?
|
Pyrazinamide | 1 | 2010 | 54 | 0.020 |
Why?
|
Quinolines | 1 | 2015 | 719 | 0.020 |
Why?
|
Luminescent Measurements | 1 | 2012 | 405 | 0.020 |
Why?
|
Narcotic Antagonists | 1 | 2014 | 562 | 0.020 |
Why?
|
Hydrocarbons, Iodinated | 1 | 2009 | 10 | 0.020 |
Why?
|
Injections | 1 | 2012 | 840 | 0.020 |
Why?
|
Alkylation | 1 | 2009 | 86 | 0.020 |
Why?
|
Microbial Sensitivity Tests | 1 | 2015 | 1871 | 0.020 |
Why?
|
History, 20th Century | 1 | 2017 | 2739 | 0.020 |
Why?
|
Consciousness | 1 | 2014 | 571 | 0.020 |
Why?
|
Psychomotor Performance | 1 | 2017 | 1895 | 0.020 |
Why?
|
Phantoms, Imaging | 1 | 2017 | 2466 | 0.020 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2016 | 1538 | 0.020 |
Why?
|
Isoniazid | 1 | 2010 | 273 | 0.020 |
Why?
|
Alcohol Drinking | 1 | 2021 | 3957 | 0.020 |
Why?
|
Rifampin | 1 | 2010 | 315 | 0.020 |
Why?
|
Stereoisomerism | 1 | 2009 | 625 | 0.020 |
Why?
|
Artifacts | 1 | 2017 | 1903 | 0.020 |
Why?
|
Intracellular Space | 1 | 2009 | 212 | 0.020 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2015 | 1183 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2016 | 6365 | 0.020 |
Why?
|
Pain Measurement | 1 | 2017 | 3418 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2021 | 5019 | 0.020 |
Why?
|
Caudate Nucleus | 1 | 2009 | 393 | 0.020 |
Why?
|
Hemodynamics | 1 | 2017 | 4197 | 0.020 |
Why?
|
Protein Denaturation | 1 | 2007 | 237 | 0.020 |
Why?
|
Diffusion | 1 | 2009 | 832 | 0.020 |
Why?
|
Thorax | 1 | 2010 | 547 | 0.020 |
Why?
|
Micelles | 1 | 2007 | 203 | 0.020 |
Why?
|
Chelating Agents | 1 | 2008 | 380 | 0.020 |
Why?
|
Protons | 1 | 2011 | 1126 | 0.020 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2017 | 2736 | 0.020 |
Why?
|
Space Perception | 1 | 2009 | 474 | 0.020 |
Why?
|
Solubility | 1 | 2007 | 1083 | 0.020 |
Why?
|
Mice, Nude | 1 | 2012 | 3689 | 0.020 |
Why?
|
Biotechnology | 1 | 2007 | 278 | 0.020 |
Why?
|
Surface Properties | 1 | 2008 | 1182 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 2014 | 1788 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2017 | 5095 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2014 | 6608 | 0.020 |
Why?
|
Biopsy | 1 | 2016 | 6756 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 7901 | 0.010 |
Why?
|
Arteries | 1 | 2009 | 1118 | 0.010 |
Why?
|
Computer Simulation | 1 | 2017 | 6191 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2017 | 3328 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2015 | 13814 | 0.010 |
Why?
|
Neoplasms | 1 | 2012 | 21596 | 0.010 |
Why?
|
Learning | 1 | 2013 | 1705 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2019 | 57683 | 0.010 |
Why?
|
Binding Sites | 1 | 2011 | 6115 | 0.010 |
Why?
|
Tuberculosis | 1 | 2015 | 1904 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2015 | 18112 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2013 | 5867 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2017 | 14554 | 0.010 |
Why?
|
Polyethylene Glycols | 1 | 2007 | 1181 | 0.010 |
Why?
|
Disease Progression | 1 | 2018 | 13256 | 0.010 |
Why?
|
Prospective Studies | 2 | 2016 | 53187 | 0.010 |
Why?
|
Cell Line | 1 | 2015 | 15994 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2017 | 19223 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2018 | 15530 | 0.010 |
Why?
|
Obesity | 1 | 2022 | 12705 | 0.010 |
Why?
|
Electroencephalography | 1 | 2014 | 6142 | 0.010 |
Why?
|
Apoptosis | 1 | 2015 | 9715 | 0.010 |
Why?
|
Pregnancy | 1 | 2021 | 29087 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2013 | 7721 | 0.010 |
Why?
|
Prognosis | 1 | 2019 | 29010 | 0.010 |
Why?
|
Body Mass Index | 1 | 2015 | 12695 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2007 | 3420 | 0.010 |
Why?
|
Infant | 1 | 2017 | 35070 | 0.010 |
Why?
|
Neurons | 1 | 2013 | 9325 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2022 | 77098 | 0.010 |
Why?
|
Substance-Related Disorders | 1 | 2009 | 4250 | 0.010 |
Why?
|
Models, Biological | 1 | 2009 | 9581 | 0.010 |
Why?
|
Mutation | 1 | 2017 | 29717 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2018 | 62966 | 0.010 |
Why?
|